Researchers have used a chemical compound to light up treatment-resistant cancers on imaging scans, in a breakthrough that ...

The researchers quantified the degree of inflammation in noncancerous lungs, namely lung regions without cancer, using AI analysis of PET/CT images. The study demonstrated that the risk of ...

PSMA-PET imaging can detect radiorecurrent prostate cancer lesions in patients even when PSA levels are below current Phoenix criteria for biochemical recurrence, investigators reported at the 2024 ...

“This detailed imaging allows for the detection of tiny nodules and is especially useful for diagnosing lung cancer at its most treatable stage,” he explains. On when should a patient get a ...

The firm presented early data for a blood-based approach to screen prostate cancer patients for PSMA, which it believes has ...

This drug approval followed the publication of the EMBARK trial, a randomized phase III trial of biochemically recurrent patients who had high-risk disease, defined by a PSA doubling time (PSADT) ≤9 ...

We read the article by Knipper et al (1) on the topic of curative treatment for localized prostate cancer with great interest. As this article was written a few months ago, We wish to add recent ...

Nuclear medicine, a specialized branch of medical science, has been making remarkable strides in oncology. Unlike ...

Reaching Rural Cancer Survivors who Smoke Using ... of 64Cu-SAR-BBN Positron emission tomography (PET)/computed tomography (CT) to correctly detect the recurrence of prostate cancer in participants ...

177Lu-PSMA-I&T therapy improved radiographic progression-free survival in metastatic castration-resistant prostate cancer patients. The ECLIPSE trial compared 177Lu-PSMA-I&T with hormone therapy, ...

(UroToday.com) The 2024 Society of Urologic Oncology (SUO) annual meeting held in Dallas, TX was host to a prostate cancer ...